Lyra Therapeutics (LYRA) Q1 2025 Earnings

13MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.74
-0.53
-0.33
-0.12

Details

Expected EPS
-0.12
Actual EPS
-0.16
Surprise EPS
-0.04
Surprise Percent
+33.33%

Description

Lyra Therapeutics (LYRA) has reported earnings of -0.16 per share for Q1 2025.

0 Comments

Share your thoughts